Angiotensin converting enzyme (ACE) is a zinc-containing dipeptidase that converts angiotensin I to angiotensin II, a powerful vasoconstrictor and smooth muscle growth factor. ACE activity has been shown to be dynamically regulated by hormones, ACE inhibitors, and endothelial cell growth state. To study how ACE expression is regulated, we isolated and sequenced the bovine ACE gene using both ACE-specific cDNA and genomic clones. Bovine ACE cDNA encodes a single polypeptide of 1,306 residues with a molecular mass of 150 kd. Bovine ACE is approximately 80%'o homologous to that of other species. It contains two homologous domains of equal size. Alignment of ACE sequences from bovine, human, mouse, and rabbit reveals that during evolution both domains have been highly conserved. We used the bovine ACE cDNA to study regulation of ACE gene expression during density-dependent growth arrest. As endothelial cells became growth-arrested (6 days after confluence), there was a 12-fold increase in ACE activity and a 90%o decrease in DNA synthesis. Immunocytochemically detectable ACE markedly increased in growth-arrested cells. The increase in ACE was due to increased ACE gene expression, as assayed by RNase protection, which showed a 20-fold increase in ACE-specific mRNA. The present study shows that bovine ACE is highly regulated by endothelial cell growth state at the level of protein and mRNA expression. Such dynamic regulation may have important consequences for angiotensin II production during endothelial cell proliferation after arterial injury
A ngiotensin converting enzyme (ACE) is a zinccontaining dicarboxypeptidase that converts angiotensin I to the potent vasoconstrictor angiotensin ll.1-3 ACE is produced by several tissue types. However, it is the production of this enzyme by vascular endothelium that is believed to be most important for systemic blood pressure regulation. ACE is localized on the luminal surface of endothelial cells as an extracellular protein, well situated to hydrolyze intravascular angiotensin I. 4 The resultant angiotensin II is in proximity to vascular smooth muscle cells, one of the critical target tissues for this peptide. Thus, a major axisregulating vascular tone is vascular smooth muscle vasoconstriction in response to endothelial production of angiotensin II.
Endothelial cell expression of ACE has been investigated in several different species using cultured endothelial cells. These studies show that several different stimuli, including steroids and other hormones, cell passage number, intracellular calcium, and ACE inhibitors, modulate endothelial ACE expression.5-9 One of the most interesting observations is that actively proliferating endothelial cells contain very little ACE; high levels of the enzyme are observed only in endothelium at confluence when the cells are relatively nonproliferative.10,11 To investigate the biochemical regulation of ACE expression as a function of bovine endothelial cell proliferation, we have undertaken the cloning of bovine ACE. Here we demonstrate that cultured bovine endothelial cells markedly upregulate ACE expression when they reach a nonproliferative state and that this is associated with a parallel increase in the amount of bovine ACE mRNA.
Materials and Methods
A bovine lung cDNA library cloned in lambda gtlO was purchased from Clontech Laboratories, Inc. A bovine genomic library in lambda DASH was also purchased from this company. DNA sequencing was performed with double-stranded plasmid DNA or portions of DNA cloned into M13 using Sequenase' and other reagents purchased from United States Biochemical Corp., Cleveland, Ohio.12,13 Sequence information was analyzed using GENEPRO (Riverside Scientific, Bainbridge Island, Wash.) and PC/GENE (IntelliGenetics, Mountain View, Calif.) software.
Bovine aortic endothelial cells were isolated from a young calf as previously described.14 The cells have the following characteristics typical of endothelial cells: growth in monolayers with a "cobblestone" appearance at confluence, uptake of 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate (Dil-Ac-LDL),15 and expression of ACE. The cells used for the studies reported in this paper were passage numbers 7-13. For cell confluence studies, cells were plated at 1x106 cells per plate on a 10-cm culture plate in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and penicillin/streptomycin at 100 units/ml and 100 ,ug/ml, respectively. Culture medium was changed every 2 days. Confluence was assessed visually and was defined as complete coverage of the tissue-culture plastic by the cell monolayer.
To determine ACE enzyme levels, endothelial cells were washed twice with 10 ml warm phosphate-buffered saline (PBS) to remove any serum components. Cells were then scraped into 5 ml ACE assay buffer (50 mM HEPES [pH 7.5] and 100 mM NaCl). The ACE assay was performed as described by Ryan and colleagues.'6"17 Briefly, 1 ml cell suspension (-0.5 mg protein) was dispensed into a tube, and Triton-X 100 was added to a final concentration of 0.05%. This was prewarmed to 37°C, and proteins were solubilized for 5 minutes. To start the assay, 50 g1 assay buffer containing 1 gCi ['H]benzoyl-phenylalanine-alanine-proline (Ventrex Laboratories, Portland, Me.) was added. Aliquots (50 ,ul) were removed at 15 and 30 minutes and acidified to prevent further reaction. The aliquots were then extracted with Ventrex scintillation cocktail No. 2, and the hydrolyzed ['H]benzoyl-phenylalanine was measured by liquid scintillation spectrometry. For determination of specific ACE activity, parallel incubations were performed containing either 1 ,uM lisinopril (an ACE inhibitor), a blank (buffer only), or a positive control (50 gug bovine kidney extract). ACE activity was defined as lisinopril-inhibitable enzyme activity. Enzyme activity was correlated to radioactivity within the scintillation cocktail using a formula based on Michaelis-Menten kinetics as described in the Ventrex protocol. Protein was determined by the method of Bradford,18 and ACE enzyme activity was expressed as units per microgram protein.
To relate the expression of ACE to cell confluence, bovine endothelial cells were plated on 35-mm tissue culture plates. These plates were then placed at a 300 angle, which caused the cells to plate in the lower half of the dish. Cells grew for 3 days, and then the dish was placed in a horizontal position. Cell proliferation occurred as the cells migrated into the section of the dish previously uncovered by media. The plated cells were fixed for 12 minutes in Bouin's solution (70% saturated picric acid solution, 25% formaldehyde solution, and 5% glacial acetic acid). They were then washed twice in 70% ethanol and twice in PBS. The cells were first incubated with 1% sheep sera for 15 minutes and then washed twice with PBS. An antibody dilution of 1: 200 of a rabbit anti-mouse ACE antisera was applied to the dishes for 1 hour at room temperature.19 In a control plate, a 1:100 dilution of rabbit preimmune sera was used. The plates were washed with PBS and reacted with biotinylated anti-rabbit immunoglobulins (LINK reagent, BioGenex Laboratories, San Ramon, Calif.) for 30 minutes at room temperature. The plates were washed with PBS, and peroxidase-conjugated streptavidin was added (LABEL reagent, BioGenex Laboratories) for 30 minutes at room temperature. The plates were washed with PBS, and a solution of 3-amino-9ethylcarbazole (Signet Laboratories) was added for 12 minutes.
To assay DNA synthesis, ['H]thymidine incorporation was measured.20 Endothelial cells were labeled in the presence of 10% serum with 1 uCi/ml [methyl-3H]thymidine (20 Ci/mmol) for 24 hours. After labeling, cells were washed with cold saline, trypsinized, and collected by centrifugation (lSOg for 5 minutes). The cell pellet was suspended in cold 10% trichloroacetic acid and agitated vigorously to lyse the cells. Nucleic acids were collected on a glass fiber filter (GF/F). After washing with cold 5% trichloroacetic acid and 70% ethanol, respectively, the filter was dried and counted in a liquid scintillation counter (model LS5000 TD, Beckman Instruments, Inc., Fullerton, Calif.).
To prepare total RNA, endothelial cells were washed with PBS (pH 7.4). Two milliliters of 4.4 M guanidine isothiocynate was added to each 10-cm plate, and the cells were scraped into this buffer. 21 The cell lysate was then passed 10 times through a 20-gauge needle. RNA was pelleted through a two-step CsCl gradient (1 ml of a 40% solution of CsCl in 10 mM Tris [pH 7.5], 1 mM EDTA (TE) layered over 3 ml of 5.7 M CsCI in TE) in an SW41 rotor (35,000 rpm for 16 hours). 22 The RNA pellet was dissolved in water, extracted with phenolchloroform, and precipitated.
A 470-base antisense riboprobe was synthesized from cDNA pBLA15. 23 The cDNA sequence of bovine angiotensin converting enzyme and the deduced amino acid sequence. The A of the initiating methionine is +1, and the A of the termination codon TGA is +3921. The amino acid sequence is indicated under the nucleotide sequence. The numbering of the nucleotide sequence is shown on the right side of the sequence, and that for the amino acid sequence is on the left. portion of the bovine transcript. To identify the 5' most coding portion of the gene, a bovine genomic library was screened with a 209-base pair Sac II fragment from the 5' end of the bovine cDNA, pBLA15. The genomic clone BG2 was isolated and a 1,500-bp portion of this clone was sequenced. Figure 1 shows the exon-intron boundaries for the first two exons based on sequence analysis of the genomic clone. Figure 2 Amino Acid Position FIGURE 4. Graph showing sequence identity of bovine, mouse, human, and rabbit angiotensin converting enzyme. The PC/GENE program CLUSTAL was used to align the amino acid sequences of mouse, human, rabbit, and bovine angiotensin converting enzyme. A consensus was then generated. Positions in which there was amino acid identity among the four sequences were marked. To quantitate sequence conservation, a window of 40 was centered at every position of the consensus, and the number of marked positions was counted. The y axis indicates thefraction ofmarkedpositions; the x axis is the position along the consensus. The reduction ofsequence homology centered at position 140 is due to a small region of nonhomologous sequence within rabbit angiotensin converting enzyme. Arrows indicate the potential zinc-binding sites in both the N-terminal and the C-terminal domains of angiotensin converting enzyme. predicts a protein of 1,306 amino acids with a postulated molecular mass of 150 kd. The composite cDNA exactly predicts the amino acid sequence determined experimentally for purified bovine ACE and indicates that bovine ACE is translated with a 28-amino acid leader sequence. 28 cDNA-encoding ACE has previously been obtained for mouse, human, and rabbit enzymes.27,29,30 ACE is a single polypeptide chain composed of two homologous domains, each with a zinc-binding and catalytic site. As in other species, the amino half of the bovine protein is similar in amino acid sequence to the carboxyl half In Figure 3 we compare the amino acid and cDNA sequence homology of bovine ACE with other published ACE sequences. As anticipated, bovine ACE exhibits high evolutionary conservation of both the amino acid and the cDNA sequences.
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To investigate interspecies sequence conservation within the described ACE molecules, mouse, human, rabbit, and bovine ACE amino acid sequences were aligned. A consensus sequence was generated with a unique character representing positions at which the identical amino acid was present in each of the four ACE sequences. A computer algorithm was then used to center a window of 40 amino acids at each position of the consensus sequence to quantify the number of positions that are absolutely conserved. This analysis (Figure 4) shows the degree of sequence identity among the ACE proteins as a function of position along the consensus. The positions of the two zinc-binding sites are indicated by arrows. The results of this comparison clearly demonstrate the evolutionary conservation within the two domains of the ACE molecule. The amino terminus and the carboxyl terminal domains appear equally conserved in sequence. The largest variation in sequence homology occurred at positions 105-143 because of a small region of the rabbit ACE sequence that was totally nonhomologous.
Using the bovine ACE cDNA, we have undertaken a detailed analysis of the regulated expression of ACE in cultured bovine aortic endothelial cells. In vivo, endothelial cells exist in a confluent nonproliferating monolayer that expresses high levels of ACE. However, upon placement in tissue culture, the cells begin to proliferate, and ACE expression is lost.10"11 It has been previously shown that growth of cultured endothelial cells to a postconfluent state causes reappearance of ACE activity. In the following experiments we have studied the molecular basis for ACE expression under these conditions: Bovine aortic endothelial cells were plated at a subconfluent density (lx 106 cells per dish) and grown continuously in the presence of 10% fetal calf serum. Within 2-3 days, the cells reached confluence and then remained viable but nonproliferative ( Figure  5 ). The change in growth state was documented by measurement of ['H]thymidine incorporation. As shown in Figure 6 , there was a progressive decrease in ['H]thymidine incorporation that reached a nadir at 6 days after confluence of approximately 10% that at 2 days before confluence (day -2). A parallel analysis of ACE expression demonstrated an inverse relation between [3H]thymidine incorporation and ACE activity ( Figure   6 ). Growth-arrested endothelial cells (6 days after confluence) had approximately 12 times (range, 10-15 times; n =3) more ACE activity than actively proliferat- ing cells (2 days before confluence). This increase in ACE was not due to a generalized increase in protein content, which did not change significantly during growth arrest (data not shown).
We next measured the levels of ACE mRNA during density-dependent growth arrest. ACE mRNA levels were measured using RNase protection of antisense bovine ACE mRNA. To control for experimental vari- ations in the protocol, a second antisense probe, bovine /3-actin, was included in each protection.25 As shown in Figure 7 , the levels of ACE mRNA in preconfluent cells were very, very low. These levels increased by 21.5-fold in 6-day postconfluent cells. Thus, there were comparable increases in ACE mRNA and ACE enzyme activity during density-dependent growth arrest (Figures 6 and 7) .
To demonstrate regulation of ACE protein expression by density-dependent growth arrest, ACE immunohistochemistry was performed on bovine endothelial cells that were growth-arrested and then allowed to proliferate. To perform this experiment, bovine endothelial cells were plated at high density (5 x 10i cells per dish) in 35-mm dishes maintained at a 300 angle. This caused immediate formation of a confluent monolayer in the lower two thirds of the dish. After 3 days of density-dependent growth arrest, dishes were placed flat in the incubator. Cells at the edge of the confluent monolayer migrated to the newly exposed area of the dish and proliferated. As shown in Figure 8D , there was a gradient of ACE expression in this region, with the migrating and proliferating endothelial cells expressing significantly less ACE than the confluent growth-arrested cells. Preimmune serum caused no significant immunohistochemical reaction ( Figure 8A ). We also observed that in the regions of densest cell growth, endothelial cell "sprouting" had occurred (Figures 8B  and 8C ). The sprouting endothelial cells formed a reticular pattern on the surface of the monolayer. They were readily identified by phase-contrast microscopy and showed striking levels of ACE by immunohistochemistry. To prove that these were endothelial cells, immunohistochemistry was performed with anti-factor VIII antibody. The sprouting endothelial cells stained as positively as the rest of the monolayer (data not shown). ACE activity was measured as described in "Materials and Methods" and is indicated with an open triangle. Parallel dishes of cells were used to prepare total RNA at 2 days before confluence (day -2) and at 0, 2 4, and 6 days after rell
confluence. An RNase protection assay was used to determine the levels of ACE mRNA. The protected ACE bands are positioned in the figure underneath the appropriate day of cell harvest. The protected ACE bands were quantitated by densitometry, and day -2 was assigned a value of 1.0. Relative levels ofACE mRNA are indicated both under the protected bands and by solid squares. These data clearly show that the amount of ACE mRNA increases after cell confluence atnd that this increase approximately parallels the increase in ACE activity. Bovine fB-actin served as a control for RNase protection and did not vary with the state of confluence of the cells.
Discussion
The major finding of this study is that ACE mRNA is regulated in endothelial cells in an inverse relation to their growth state. Regulation of ACE activity in endothelium is important because of the mounting evidence that the renin-angiotensin system is important not only in vascular tone but also in vascular growth.31 In particular, recent findings that ACE inhibitors prevent intimal proliferation in rat carotid artery models of balloon injury have suggested an important role for ACE in the pathogenesis of restenosis.32 Future experiments are planned to document the time course for endothelial cell ACE expression after injury.
The present study also shows that ACE has been highly conserved during evolution. In particular, our analysis of bovine, murine, human, and rabbit ACE eDNA suggests that the amino and carboxyl domains of ACE have been equally conserved. Whereas it was once thought that ACE contained one molar equivalent of zinc, it is now recognized that each of the two domains of the ACE polypeptide can bind zinc and function catalytically.3335 As demonstrated by Wei et al,35 the two domains differ in the K,at for hydrolysis of angiotensin I: the carboxyl domain has a threefold to ninefold higher K,3, depending on the substrate. The fact that the testis isozyme of ACE contains only the carboxyl domain has led people to question whether the amino domain functions in vivo. The present study supports the idea that the amino domain has a catalytic function, because it seems to be as evolutionarily conserved as the carboxyl domain. These data are consistent with the results of in vitro expression of the individual ACE domains. 35 Many recent studies have emphasized the role of the endothelium in the homeostatic regulation of blood pressure. One important aspect of this regulation is that endothelium is a major source of ACE and thus acts to produce angiotensin II. This peptide has many physiological effects including vasoconstriction, aldosterone production by the adrenal gland, and water reabsorption by the kidney. Thus, endothelial ACE activity should have a direct bearing on the regulation of blood pressure.
ACE activity has been documented to be regulated by a wide variety of stimuli in vivo and in vitro. For example. steroids upregulate expression, whereas insulin has been reported to downregulate expression.5 One of the most intriguing observations has been the apparent lack of endothelial cell ACE activity during cell proliferation and increased activity during density-dependent growth arrest.'1 The fact that endothelial cells are normally present in a nonproliferating confluent monolayer suggests that ACE expression is a feature of a more differentiated (i.e., functionally equivalent to in vivo) endothelial cell phenotype. In the present study we now show that this regulation is mediated by an increase in steady-state mRNA levels for ACE. This was a specific effect in that there was no change for the constitutively expressed /3-actin mRNA.
Although the mechanisms responsible for induction of ACE mRNA by density-dependent growth arrest remain unknown, the immunohistochemical studies performed in this work offer some intriguing insights into a possible role for ACE. In these studies, we demonstrated a marked increase in ACE expression in areas where cells were growth-arrested (as predicted from our mRNA and protein activity data) compared with proliferating areas. Of interest, in areas of very confluent cells, the greatest amount was found in cells that appeared to be sprouting. ACE is known to catalyze the hydrolysis of several biologically active polypeptides in addition to angiotensin 1.36 It is plausible that expression of a peptidase such as ACE during endothelial cell sprouting may reflect an in vivo role in processes such as angiogenesis.
The mechanisms responsible for increased ACE mRNA remain unknown. Endothelial cell ACE mRNA regulation should be an excellent model system to study the roles of cell-to-cell contact, cell shape, cell matrix, and cessation of cell growth in regulation of gene expression. FIGURE 8. Photomicrographs showing angiotensin converting enzyme protein expressiont in growth-arrested and proliferating endothelial cells. Panel A: Postconfluent cells treated with rabbit preimmuine sera. There is minimal backgrouind staining. Panel B: Postconfluent cells treated with a 1:200 dilution of a polyclonal rabbit anti-angiotensin converting enzyme antibody. There is intense staininig of sprouting endothelial cells in an area of the plate that is 6 days postconfluenit. Panel C: High power of the sproutinig cells. The majority of angiotensin converting enzyme activity appears to be withint these cells, althouigh the nonsprouting cells also stain for angiotensin converting enzyme. Panel D: The tranisition zone oni the plate whlere the cells are 6 days postconfluent (left) and proliferating (right). Although there is on ly a minimal increase in cell density on thle left, there is a great increase in angiotensitn converting enzyme activity.
